NUP93在肾脏的表达及其突变致局灶节段性肾小球硬化的机制
该研究通过免疫荧光分析正常对照肾脏和携带NUP93突变的FSGS患者肾脏,发现NUP93表达于所有肾小球和肾小管间质细胞核。患者肾脏中肾小球及肾外细胞核内NUP93荧光强度显著降低,而足细胞CD2AP和nephrin表达相对完整。外周血单个核细胞中NUP93蛋白量无显著改变。结论提示NUP93突变可能通过改变肾脏细胞NUP93表达导致SRNS/FSGS。
要点
- NUP93表达于人类肾脏所有肾小球和肾小管间质细胞核。
- NUP93突变患者肾小球及肾外细胞核NUP93荧光强度显著降低。
- 患者足细胞CD2AP和nephrin表达相对完整,外周血NUP93蛋白量无显著改变。
核心结论
- NUP93表达于人类肾脏所有类型细胞核,NUP93突变导致肾小球及肾外细胞NUP93表达改变,可能是SRNS/FSGS的致病机制。
研究设计与样本
- 研究采用免疫荧光分析正常对照肾脏和携带NUP93突变的FSGS患者肾脏,并用Western blot分析血细胞中NUP93表达。
- 通过全外显子测序在一名6岁进展至ESRD的FSGS患者中鉴定出复合杂合NUP93突变,包括新发错义突变p.Arg525Trp和已报道的p.Tyr629Cys。
主要发现
- 免疫荧光分析显示NUP93表达于人类肾脏所有肾小球和肾小管间质细胞核。
- 患者肾脏中肾小球和肾外细胞核内NUP93免疫荧光强度显著降低。
- 患者足细胞中CD2AP和nephrin表达相对完整。
- 患者外周血单个核细胞中NUP93蛋白量无显著改变。
临床怎么用
- 对于儿童期发病的SRNS或FSGS,尤其进展至ESRD者,可考虑NUP93基因检测。
- 肾活检免疫荧光显示NUP93核表达降低可能提示NUP93突变相关FSGS。
局限性
- 研究仅基于一名患者,样本量有限。
- NUP93突变导致FSGS的具体分子机制尚未完全阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Mutations in genes encoding nucleoporins (NUPs; components of nuclear pore complexes [NPCs]), such as NUP93, have been reported to cause steroid-resistant nephrotic syndrome (SRNS) or focal segmental glomerulosclerosis (FSGS), which often progresses to end-stage renal disease (ESRD) in childhood. The expression of NUP93 in renal or extrarenal tissues, and the mechanism by which NUP93 mutations cause this renal phenotype, remain unclear. METHODS: The expression of NUP93 in normal control kidney and in a patient with FSGS carrying NUP93 mutations was examined by immunofluorescence analysis. The expression of NUP93 in blood cells was analyzed by Western blot analysis. RESULTS: Immunofluorescence analysis detected NUP93 expression in nuclei of all glomerular and tubulointerstitial cells in human kidneys. Whole-exome sequencing identified a compound heterozygous NUP93 mutation comprising a novel missense mutation p.Arg525Trp, and a previously reported mutation, p.Tyr629Cys, in a patient with FSGS that developed ESRD at the age of 6 years. In the patient's kidney, the intensity of NUP93 immunofluorescence was significantly decreased in the nuclei of both glomerular and extraglomerular cells. The expression of CD2-associated protein (CD2AP) and nephrin in the patient's podocytes was relatively intact. The amount of NUP93 protein was not significantly altered in the peripheral blood mononuclear cells of the patient. CONCLUSION: NUP93 is expressed in the nuclei of all the cell types of the human kidney. Altered NUP93 expression in glomerular cells as well as extraglomerular cells by NUP93 mutations may underlie the pathogenic mechanism of SRNS or FSGS.
引用
- Hashimoto T, Harita Y, Takizawa K, et al. In Vivo Expression of NUP93 and Its Alteration by NUP93 Mutations Causing Focal Segmental Glomerulosclerosis. Kidney Int Rep. 2019. PMID: 31517150. doi:10.1016/j.ekir.2019.05.1157
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。